Patents Assigned to Osteotrophin, LLC
  • Patent number: 7384912
    Abstract: Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: June 10, 2008
    Assignee: Osteotrophin, LLC
    Inventor: Andrew F. Stewart
  • Patent number: 7015195
    Abstract: Disclosed herein are methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of metabolic bone disorders that are both effective and have an increased safety.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: March 21, 2006
    Assignee: Osteotrophin, LLC
    Inventor: Andrew F. Stewart